Physicians' Agreement on and Implementation of the 2019 European Alliance of Associations for Rheumatology Vaccination Guideline: An International Survey|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Objective: To evaluate the perspective of healthcare professionals towards the 2019 European Alliance of Associations for Rheumatology (EULAR) vaccination guideline in patients with autoimmune inflammatory rheumatic diseases (AIIRD).
Methods: Healthcare professionals who care for patients with AIIRD were invited to participate in an online survey regarding their perspective on the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. Level of agreement and implementation of the 6 overarching principles and 9 recommendations were rated on a 5-point Likert scale (1~5).
Results: Survey responses of 371 healthcare professionals from Asia (42.2%) and North America (41.6%), Europe (13.8%), and other countries were analyzed. Only 16.3% of participants rated their familiarity with the 2019 EULAR guideline as 5/5 (“very well”). There was a high agreement (≥4/5 rating) with the overarching principles, except for the principles applying to liveattenuated vaccines. There was a high level of agreement with the recommendations regarding influenza and pneumococcal vaccinations; implementation of these recommendations was also high. Participants also reported a high level of agreement with the remaining recommendations but did not routinely implement these recommendations.
Conclusion: The 2019 update of EULAR recommendations for the vaccination of adult patients with AIIRD is generally thought to be important by healthcare professionals, although implementation of adequate vaccination is often lacking. Better education of healthcare providers may be important to optimize the vaccination coverage for patients with AIIRD.

번역하기

참고문헌 (Reference)

1 Morin MP, "Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre" 51 : 2046-2050, 2012

2 Park JK, "Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis : post hoc analysis of a randomised clinical trial" 78 : 1283-1284, 2019

3 Krasselt M, "Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic" 37 : 229-237, 2017

4 Hmamouchi I, "Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis : data from the international COMORA cohort" 33 : 1446-1452, 2015

5 Brocq O, "Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint : a retrospective study" 83 : 155-159, 2016

6 Danza A, "Infection risk in systemic lupus erythematosus patients : susceptibility factors and preventive strategies" 22 : 1286-1294, 2013

7 Park JK, "Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis : a randomised clinical trial" 77 : 898-904, 2018

8 Au K, "High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis" 70 : 785-791, 2011

9 Doran MF, "Frequency of infection in patients with rheumatoid arthritis compared with controls : a population-based study" 46 : 2287-2293, 2002

10 Park JK, "Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis : a randomised clinical trial" 76 : 1559-1565, 2017